Background: There is high prevalence of mood disorders in patients with systemic scleroderma. Psychical distress can influent some of clinical manifestations and can worse the course of the disease and socioeconomicall status of patients. Objectives: The aim of study is detection of correlations of depression and psychological profile measures by MMPI-II (The Minnesota Multiphasic Personality Inventory) and BDI-II (The Beck Depression Inventory-II) and organ manifestation and immunological profile of patients with systemic sclerosis.
prior to RTX. At the end of follow-up, no significant change was revealed in FVC when compared with pre-RTX values [58.0 (44.7-58 .7), p=0.065]. FVC was improved in four patients and stabilized remaining ten patients. All of the patients with improvement of PFTs had moderate or severe restrictive lung disease. High resolution thorax computed tomography (HRCT) findings remained stable in 7 and showed progression of ILD in 3 patients. In total, mRSS remained stable at the end of follow-up when compared with baseline [8.0 (5.2-12. 2) vs. 6.0 (4.0-12.2),p=0,026]. (Diasorin, Italy) . Pulmonary function test, chest x-ray, lung CT scan, electrocardiography, Doppler echocardiography, renal artery resistive index by eco color Doppler, Dual X-ray absorptiometry, were performed at the time of sample collection. Disease severity scale (DSS) was performed according to Medsger. Drug assumption (glucocorticoids, calcium channel blockers, cyclic intravenous iloprost, endothelin receptor antagonists) and supplementation with vitamin D analogues, were recorded. Non-parametric tests were used for statistical analysis. Results: Average 25(OH)D serum concentration was found to be 18.7±9 ng/ml (<20 classified as deficiency). A significant difference was observed among seasonal 25(OH)D serum concentration (winter: 14.6±7.8 ng/ml, spring: 17.2±7.9 ng/ml, summer 21.43±10 ng/ml, autumn 20.2±10; p=0.032) (Figure 1 ). A significant correlation was found between 25(OH)D serum concentration and presence/absence of bi-basal fibrotic changes at lung computed tomography (CT) scan (average values: 16.1±8 ng/ml and 20±10 ng/ml, respectively, p=0.04). Peripheral vascular (p=0.03), kidney (p=0.02), gastrointestinal (p=0.05) Medsger's DSS parameters also were found to correlate with 25(OH)D serum concentration ( Figure 1 ). Interestingly, no influence of treatment with vitamin D analogues (1,000 UI daily) was found regarding 25(OH)D serum concentration in treated (18.8±10 ng/ml) and in not treated (18.7±9 ng/ml) SSc patients (p=0.81).
Conclusions:
In SSc is confirmed a serum 25(OH)D deficiency that we report to be associated with lung involvement, peripheral vascular, kidney and gastrointestinal Medsger's DSS parameters, as well as with seasonality. Supplementation with vitamin D analogues did not influence present results. 
Methods:
We conducted a retrospective analysis of 110 pts with SSc followed in our Rheumatology department and selected those who performed lung ventilation/perfusion scintigraphy (V/Q scan) or CT pulmonary angiography due to worsening dyspnea/fatigue or isolated reduction of the carbon monoxide diffusing capacity (DLCO). We collected demographic features, comorbidities, age at SSc diagnosis, anti-nuclear antibody specificities, dyspnea according to New York Heart Association (NYHA) classes and results of cardiopulmonary exams. PE and related variables were assessed at baseline and after 12 months of ACO. Results: PE was diagnosed in 12 out of 29 (41.4%) SSc pts that met inclusion criteria, with the majority presenting bilateral peripheral multisegmental defects. Most were females (91.7%), mean age of 59.4 (±12.7) years (yrs). Two thirds were diagnosed with limited SSc with mean disease duration of 13.3 (±12.9) yrs. Mean time between SSc and PE diagnosis was 8.5±8.2 yrs, although one third of the pts was diagnosed within the first year of SSc diagnosis. One patient was taking oral contraceptives and none had thrombophilia, previous surgery or cancer.
One third was classified as having NYHA class≥3, with a mean N-terminal pro-brain natriuretic peptide (NTproBNP) of 1108pg/mL (19 to 8069). Six pts had concomitant interstitial lung disease (ILD) and 8 had an estimated pulmonary artery systolic pressure (PASP)≥35 mmHg (6 of them had concomitant ILD). From these only 2 had pulmonary hypertension confirmed by right heart catheterization and 1 died. When comparing SSc pts with and without PE, Scl70 positivity was more common in pts with PE (p=0.041). No significant associations were found between PE and several cardiovascular risk factors. From the 12 pts with PE, 10 were on longterm ACO:5 on rivaroxaban, 4 on warfarin and 1 on apixaban. Clinical reassessment after 12 months of ACO is shown in figure 1.
Conclusions:
Our results suggest that PE is frequent in SSc and must be considered in the differential diagnosis of worsening fatigue and dyspnea and/or reduction of DLCO/PASP increase. PE may occur more frequently in Scl70 positive pts and early in disease course, probably due to vasculopathy and vascular injury being more prominent in the early phase of the disease. Although there is no consensus regarding the optimal ACO, the disease's vasculopathy seems to be an important contributor, potentially preventing improvement in perfusion defects, regardless of the anticoagulant used. Background: Systemic sclerosis (ScS) has unpredictable course and high mortality. Generalised Estimating Equations (GEE) is a technique useful for longitudinal data analysis, using data from all time points and adjusting for within-patient correlation,i.e. correlation between time points within the same patient. GEE does not require a normal distribution of dependent variables, making it attractive for analyzing SSc data. Objectives: To identify predictive factors for death and unfavorable outcomes. Methods: Data of SSc patients with ≥2 visits in our EUSTAR centre in 2004-2016 were analyzed. GEE investigated the relationship over time between outcomes (death, digital ulcers (DUs), forced vital capacity (FVC), modified Rodnan skin score (mRSS)) and potential predictors (age, gender, disease duration, cutaneous subset, mRSS at baseline, DUs history, DLCO, left ventricle ejection fraction (LVEF), proteinuria), separately for each predictor and in combined models. Results: 89 patients (12.4%males, mean±SD age 49.2±12.2years, disease duration 4.1±7.5years) were included, with a follow-up of up to 13years. There were 14deaths, most due to lung involvement (7/14). In multivariable GEE analysis (Table 1) , predictors of death were a shorter disease duration, DUs history, and a lower LVEF. Predictors for FVC decrease over time were difuse cutaneous subset (dcSSc), younger age and lower DLCO. Younger age, shorter disease duration and higher baseline mRSS were the most important predictors for higher mRSS at follow-up. The only predictor for the development of new DUs was a history of DUs. 
Patients with shorter disease duration, dcSSc, higher mRSS, lower DLCO and LVEF and a history of DUs had a more unfavorable course. GEE is a robust technique for longitudinal data analysis, excellent for identifying prediction factors in SSc.
